New facility at the Bio-Technopark Zurich in Schlieren

Neurimmune announced that the company will relocate into a state-of-the-art 30,000 Sq Ft facility at the Bio-Technopark Zurich in Schlieren as of January 1, 2009. Due to the urgent requirements for well-developed and equipped laboratories for its future development, Neurimmune decided to relocate from its current facility at the University of Zurich to a new state-of-the-art research facility at the Biotechnopark in Schlieren, Zurich.